A multicentre, double-blind, randomised, parallel group, placebo-controlled, dose-ranging pilot study of ethyl-eicosapentaenoate (ethyl-EPA) in patients with schizophrenia Not provided at time of registration

• Pays United Kingdom
• Organes Aucun
• Spécialités Aucune

A multicentre, double-blind, randomised, parallel group, placebo-controlled trial of LAX-101 (ethyl eicosapentaenoate [EPA]) in patients with a new or recurrent episode of depression Not provided at time of registration

• Pays United Kingdom
• Organes Aucun
• Spécialités Aucune

A multicentre, double-blind, randomised, parallel group, placebo-controlled, dose ranging pilot study of ethyl eicosapentaenoate (EPA) as adjunct therapy in patients who remain depressed following treatment with standard antidepressant therapy Not provided at time of registration

• Pays United Kingdom
• Organes Aucun
• Spécialités Aucune

A multicentre, double-blind, randomised, parallel group, placebo-controlled trial of LAX-101 (ethyl eicosapentaenoate [EPA]) as adjunct therapy in patients who remain depressed following treatment with standard antidepressant therapy Not provided at time of registration

• Pays United Kingdom
• Organes Aucun
• Spécialités Aucune

A multicentre, multinational, double blind, randomised, parallel group, placebo-controlled study of ethyl-eicosapentaenoate (EPA) in patients with Huntington's disease (HD) Not provided at time of registration

• Pays United Kingdom
• Organes Aucun
• Spécialités Aucune